📰 Efficacy Study News
Page 4 - Efficacy Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Efficacy Study. Real-time updates on events, politics, business and more.
August 25, 2022
Investegate announcements from AstraZeneca PLC, Ultomiris approved in Japan for gMG
May 23, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 19, 2022
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congre...
April 2, 2022
Dr. Denise Galloway was elected a member of the American Association for Cancer Research Academy. The Fred Hutchinson Cancer Research Center cancer biologist studies the links between certain viruses and cancer. Her work on HPV helped make the cancer-preventive HPV vaccine possible.
March 31, 2022
Significance Statement Iron supplementation and erythropoiesis-stimulating agents (ESAs) are curr
March 22, 2022
Dr. Denise Galloway was elected a member of the American Association for Cancer Research Academy. The Fred Hutchinson Cancer Research Center cancer biologist studies the links between certain viruses and cancer. Her work on HPV helped make the cancer-preventive HPV vaccine possible.
January 24, 2022
Find out the best nootropic stacks and brain supplements of 2022 based on user reviews and other forms of user engagement.
December 21, 2021
Investegate announcements from AstraZeneca PLC, Ultomiris accepted for FDA Priority Review for gMG
December 21, 2021
Submission based on positive Phase III trial in which Ultomiris significantly improved functional activities as measured by Myasthenia Gravis-Activities of Daily Living Profile
October 1, 2021
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...